首页> 美国政府科技报告 >Experimental Approaches R34000, A Dioxolane Imidazole in the Therapy for Experimental Coccidioidomycosis. Comparison with Miconazole and Econazole.
【24h】

Experimental Approaches R34000, A Dioxolane Imidazole in the Therapy for Experimental Coccidioidomycosis. Comparison with Miconazole and Econazole.

机译:实验方法R34000,二氧戊环咪唑治疗实验性球孢子菌病。与咪康唑和益康唑的比较。

获取原文

摘要

Comparisons were made on the therapeutic influence of three imidazole drugs in experimental lethal coccidioidomycosis of mice. When administered by the intramuscular route, miconazole and a closely related structural analogue, econazole, were effective in preventing death, restricting fungal replication in the lungs, and minimizing the extent of extrapulmonary dissemination. Neither drug was as effective when administered by the oral route as by the intramuscular route. This contrasted sharply with results obtained using R34000, a dioxolane imidazole. It was very highly effective when administered by the oral route and less so by intramuscular injection. All orally treated mice survived a challenge lethal to more than 80 percent of control animals. Plasma or serum concentrations of orally administered R34000 in mice and in man exceeded the minimum inhibitory concentration for a virulent strain of Coccidioides immitis. (Author)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号